These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 35381832)
1. Upregulated expression of NOP2 predicts worse prognosis of gastric adenocarcinoma by promoting tumor growth. Feng J; Zhang J; Li Y; Wang J; Mo P; Lin L Saudi J Gastroenterol; 2022; 28(5):369-377. PubMed ID: 35381832 [TBL] [Abstract][Full Text] [Related]
2. High HOXD4 protein expression in gastric adenocarcinoma tissues indicates unfavorable clinical outcomes. Liu H; Tian H; Zhao J; Jia Y Saudi J Gastroenterol; 2019; 25(1):46-54. PubMed ID: 30588951 [TBL] [Abstract][Full Text] [Related]
3. TRIM15 Exerts Anti-Tumor Effects Through Suppressing Cancer Cell Invasion in Gastric Adenocarcinoma. Chen W; Lu C; Hong J Med Sci Monit; 2018 Nov; 24():8033-8041. PubMed ID: 30412518 [TBL] [Abstract][Full Text] [Related]
4. Clinical significance of kallikrein 5 as a novel prognostic biomarker in gastric adenocarcinoma. Abuduhadeer X; Xu X; Aihesan K; Yilihamu M; Zhao Y; Zhang W J Clin Lab Anal; 2021 Oct; 35(10):e23958. PubMed ID: 34510543 [TBL] [Abstract][Full Text] [Related]
5. Nuclear protein NOP2 serves as a poor-prognosis predictor of LUAD and aggravates the malignancy of lung adenocarcinoma cells. Qin W; Fei G; Zhou Q; Li Z; Li W; Wei P Funct Integr Genomics; 2024 Mar; 24(2):58. PubMed ID: 38489049 [TBL] [Abstract][Full Text] [Related]
6. Nucleolar protein NOP2 could serve as a potential prognostic predictor for clear cell renal cell carcinoma. Wang G; Qu F; Liu S; Zhou J; Wang Y Bioengineered; 2021 Dec; 12(1):4841-4855. PubMed ID: 34334108 [TBL] [Abstract][Full Text] [Related]
7. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer. Guo J; Zu G; Zhou T; Xing J; Wang Z Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133 [TBL] [Abstract][Full Text] [Related]
8. Yeast NOP2 encodes an essential nucleolar protein with homology to a human proliferation marker. de Beus E; Brockenbrough JS; Hong B; Aris JP J Cell Biol; 1994 Dec; 127(6 Pt 2):1799-813. PubMed ID: 7806561 [TBL] [Abstract][Full Text] [Related]
9. Decreased expression of transcription elongation factor A-like 7 is associated with gastric adenocarcinoma prognosis. Huang CY; Chen YM; Zhao JJ; Chen YB; Jiang SS; Yan SM; Zhao BW; Pan K; Wang DD; Lv L; Li YF; Wang W; Zhou ZW; Xia JC PLoS One; 2013; 8(1):e54671. PubMed ID: 23372750 [TBL] [Abstract][Full Text] [Related]
10. Decreased expression of SEMA3A is associated with poor prognosis in gastric carcinoma. Tang C; Gao X; Liu H; Jiang T; Zhai X Int J Clin Exp Pathol; 2014; 7(8):4782-94. PubMed ID: 25197349 [TBL] [Abstract][Full Text] [Related]
11. TPX2 expression is associated with poor survival in gastric cancer. Tomii C; Inokuchi M; Takagi Y; Ishikawa T; Otsuki S; Uetake H; Kojima K; Kawano T World J Surg Oncol; 2017 Jan; 15(1):14. PubMed ID: 28069036 [TBL] [Abstract][Full Text] [Related]
12. High RSF-1 expression correlates with poor prognosis in patients with gastric adenocarcinoma. Hu BS; Yu HF; Zhao G; Zha TZ Int J Clin Exp Pathol; 2012; 5(7):668-73. PubMed ID: 22977663 [TBL] [Abstract][Full Text] [Related]
13. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer. Wang YY; Ye ZY; Zhao ZS; Tao HQ; Chu YQ Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999 [TBL] [Abstract][Full Text] [Related]
14. Clinicopathological association of CD93 expression in gastric adenocarcinoma. Shen Y; Wu Y; Hao M; Fu M; Zhu K; Luo P; Wang J J Cancer Res Clin Oncol; 2024 Aug; 150(8):400. PubMed ID: 39190192 [TBL] [Abstract][Full Text] [Related]
15. The overexpression of MDM4: an effective and novel predictor of gastric adenocarcinoma lymph node metastasis. Bao J; Nanding A; Song H; Xu R; Qu G; Xue Y Oncotarget; 2016 Oct; 7(41):67212-67222. PubMed ID: 27626496 [TBL] [Abstract][Full Text] [Related]
16. Upregulated Solute Carrier SLC39A1 Promotes Gastric Cancer Proliferation and Indicates Unfavorable Prognosis. Yu D; Chen Y; Luo M; Peng Y; Yi S Genet Res (Camb); 2022; 2022():1256021. PubMed ID: 36407082 [TBL] [Abstract][Full Text] [Related]
17. Nuclear overexpression of the overexpressed in lung cancer 1 predicts worse prognosis in gastric adenocarcinoma. Wang J; Shen H; Fu G; Zhao D; Wang W Oncotarget; 2017 Feb; 8(6):9442-9450. PubMed ID: 28038462 [TBL] [Abstract][Full Text] [Related]
18. Ezrin overexpression predicts the poor prognosis of gastric adenocarcinoma. Jin J; Jin T; Quan M; Piao Y; Lin Z Diagn Pathol; 2012 Oct; 7():135. PubMed ID: 23039327 [TBL] [Abstract][Full Text] [Related]
19. MCM-2 and MCM-5 expression in gastric adenocarcinoma: clinical significance and comparison with Ki-67 proliferative marker. Giaginis C; Giagini A; Tsourouflis G; Gatzidou E; Agapitos E; Kouraklis G; Theocharis S Dig Dis Sci; 2011 Mar; 56(3):777-85. PubMed ID: 20694513 [TBL] [Abstract][Full Text] [Related]
20. Twist1 correlates with poor differentiation and progression in gastric adenocarcinoma via elevation of FGFR2 expression. Zhu DY; Guo QS; Li YL; Cui B; Guo J; Liu JX; Li P World J Gastroenterol; 2014 Dec; 20(48):18306-15. PubMed ID: 25561797 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]